Effects of fatty acids on metabolism in patients with a specific deficiency and healthy individuals
Metabolic Effects of Medium-Chain Fatty Acids in Patients With Medium-Chain Acyl-CoA Dehydrogenase Deficiency and Healthy Individuals
This study tests how different types of fatty acids affect metabolism in people with Medium-Chain Acyl-CoA Dehydrogenase Deficiency and healthy individuals.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | University of Copenhagen Academic / other |
| Locations | 1 site (Copenhagen) |
| Trial ID | NCT06623032 on ClinicalTrials.gov |
What this trial studies
This study investigates the physiological effects of medium-chain fatty acids (MCFA) and long-chain fatty acids (LCFA) in individuals diagnosed with Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) and healthy participants. It employs a randomized crossover design with two test days, where participants will ingest either MCFA or LCFA in the form of triacylglycerol oils. The order of ingestion is randomized to assess the metabolic responses to each type of fatty acid. The study aims to provide insights into lipid metabolism and potential dietary recommendations for MCADD patients.
Who should consider this trial
Good fit: Ideal candidates include males and females aged 18-80 who have been diagnosed with Medium-Chain Acyl-CoA Dehydrogenase Deficiency.
Not a fit: Patients with diabetes, kidney or liver disease, or those on specific medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved dietary guidelines and management strategies for patients with MCADD.
How similar studies have performed: While there is limited data on similar studies, the investigation of fatty acid metabolism is a well-explored area, suggesting potential for meaningful insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria MCADD patients: * Male or female * Age between 18-80 years old * Diagnosed Medium-chain acyl-CoA dehydrogenase deficiency (MCADD Inclusion Criteria Healthy Participants: * Male or female * Age between 18-80 years old Exclusion Criteria both MCADD patients and healthy participants: * Diabetes * Kidney- or liver disease * Use of beta blockers or diuretics * Pregnant, lactating or planning to become pregnant within the study period * Regular intake of substantial amounts of coconut oil, palm kernel oil or any other source abundant in MCFA * Ongoing cancer treatment * Metabolic or absorptive disorders, gastric bypass operation, or use of medication affecting metabolism or food absorption * Inability, physically or mentally, to comply with the procedure required by the study protocol as evaluated by the primary investigator, study manager or clinical responsible
Where this trial is running
Copenhagen
- University of Copenhagen — Copenhagen, Denmark (Recruiting)
Study contacts
- Principal investigator: Andreas M Fritzen, Associate Professor — University of Copenhagen
- Study coordinator: Kasper S Jørgensen, PhD student
- Email: kaspersuhr@sund.ku.dk
- Phone: +4523473023
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.